Take a closer look at some of the statistics generated by The Scientist's Best Place to Work Industry 2013 survey.
By The Scientist Staff | June 1, 2013
BPTW: By The Numbers Image Gallery
Read the full story.
Sign In with your LabX Media Group Passport to leave a comment
Not a member? Register Now!
By Tracy Vence
Meanwhile, Allergan acquires drug developer Naurex in a $560 million deal.
By Jef Akst
The US Department of Health and Human Services will put nearly $20 million toward the development of an Ebola drug as Tekmira steps out of the space.
By Kerry Grens
Celgene has purchased Receptos, developer of an experimental multiple sclerosis drug.
Kepler-452b revolves around a sun much like our own.
Ethical issues attend the creation of animal-human chimeras.
Multiple consecutive adenosine nucleotides can cause protein translation machinery to stall on messenger RNAs.
In some pathogenic bacteria, certain antibiotic resistance–associated mutations may also confer an unexpected growth advantage.
View the July 2015 contents.
© 1986-2015 The Scientist